Vifor Pharma AG Performance
Vifor Pharma Relative Risk vs. Return Landscape
If you would invest (100.00) in Vifor Pharma AG on October 9, 2024 and sell it today you would earn a total of 100.00 from holding Vifor Pharma AG or generate -100.0% return on investment over 90 days. Vifor Pharma AG is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded stocks are less volatile than Vifor, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Vifor Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vifor Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Vifor Pharma AG, and traders can use it to determine the average amount a Vifor Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| VIFNE |
Based on monthly moving average Vifor Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vifor Pharma by adding Vifor Pharma to a well-diversified portfolio.
Things to note about Vifor Pharma AG performance evaluation
Checking the ongoing alerts about Vifor Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Vifor Pharma AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vifor Pharma AG is not yet fully synchronised with the market data | |
| Vifor Pharma AG has some characteristics of a very speculative penny stock |
- Analyzing Vifor Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vifor Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Vifor Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vifor Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vifor Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vifor Pharma's stock. These opinions can provide insight into Vifor Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Vifor Stock
If you are still planning to invest in Vifor Pharma AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vifor Pharma's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |